Supplementary Figures 1-2 from Preclinical &lt;i&gt;In vivo&lt;/i&gt; Evaluation of Efficacy, Pharmacokinetics, and Pharmacodynamics of a Novel MEK1/2 Kinase Inhibitor RO5068760 in Multiple Tumor Models